Fellows
Dilan A. Patel

Dilan A. Patel, MD

Advanced BMT Fellow

Began fellowship in 2020

Biosketch

Education
2006-2010 BA, Interdisciplinary Degree in Medicine, Health, and Society, Vanderbilt University, Nashville, TN
2010-2014 MD, University of Tennessee Health Science Center, Memphis, TN
Post-graduate Training
2014-2017 Internal Medicine Residency, Washington University School of Medicine, St. Louis, MO
2017-2020 Hematology/Oncology Fellowship, Vanderbilt University School of Medicine, Nashville, TN
Honors & Awards
2012 Albright Armstrong Rice Scholarship at UTHSC
2013 Gold Humanism Honor Society Inductee
2014 Outstanding Student Services Award at UTHSC College of Medicine
2016, 2019 ASH Abstract Achievement Award
2017 Washington University School of Medicine Resident Leadership Award
2020 ASTCT Travel Grant
2020 Most Outstanding Fellow Teaching Award, Vanderbilt University Medical Center

Peer-reviewed Journal Articles

  • Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant
    Patel DA, Mendoza KA, Chen H, Engelhardt BG, Savani BN, Goodman SA, Warner J, Kassim AA, Byrne M, Chinratanalab W, Greer JP, Hunt C, Jagasia M
    J Hematol 2021 Feb;10(1):35-39
  • New-Onset Post-Transplant Diabetes Mellitus After Haploidentical Hematopoietic Cell Transplant With Post-Transplant Cyclophosphamide
    Mangan BL, Patel D, Chen H, Gatwood KS, Byrne MT, Sengsayadeth S, Goodman S, Dholaria B, Kassim AA, Jagasia M, Chinratanalab W, Culos KA, Engelhardt BG
    EJHaem 2020 Nov;1(2):576-580
  • Dural Marginal Zone Lymphoma in a Patient With a Hepatitis C Virus Infection
    Villaume MT, Patel D, Lopez C, Patel V, Diggs P, Harmsen H, Thompson MA, Morgan D
    World J Oncol 2020 Jun;11(3):122-125
  • Haploidentical Bone Marrow Transplant With Posttransplant Cyclophosphamide for Sickle Cell Disease: An Update
    Patel DA, Akinsete AM, de la Fuente J, Kassim AA
    Hematol Oncol Stem Cell Ther 2020 Jun;13(2):91-97
  • Risk Factors Associated With Early Viral Reactivation Following Haploidentical Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide: A Pilot Study
    Baskett J, Culos KA, Satyanarayana G, Patel D, Engelhardt B, Savani B, Jagasia M, Kassim AA, Gatwood KS
    Ann Hematol 2020 May;99(5):1137-1139
  • Minimal Residual Disease Negativity and Lenalidomide Maintenance Therapy Are Associated With Superior Survival Outcomes in Multiple Myeloma
    Patel DA, Gopalakrishnan R, Engelhardt BG, McArthur E, Sengsayadeth S, Culos KA, Byrne M, Goodman S, Savani BN, Chinratanalab W, Jagasia M, Mosse CA, Cornell RF, Kassim AA
    Bone Marrow Transplant 2020 Jun;55(6):1137-1146
  • Early Viral Reactivation Despite Excellent Immune Reconstitution Following Haploidentical Bone Marrow Transplant With Post-Transplant Cytoxan for Sickle Cell Disease
    Patel DA, Dhedin N, Chen H, Karnik L, Gatwood K, Culos K, Mohan S, Engelhardt BG, Kitko C, Connelly J, Satyanarayana G, Jagasia M, De La Fuente J, Kassim A
    Transpl Infect Dis 2020 Feb;22(1):e13222
  • Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone
    Erath A, Patel DA, Hosack EA, Patanella JE, Ibach DM, Kassim AA
    World J Oncol 2020 Feb;11(1):33-36
  • Implication of Rituximab Infusion Reactions on Clinical Outcomes in Patients With Diffuse Large B-Cell Lymphoma: A Single Institution Experience
    Patel DA, Johanns TM, Trinkaus K, Bartlett NL, Wagner-Johnston N, Cashen AF
    Clin Lymphoma Myeloma Leuk 2019 Dec;19(12):806-811
  • Improvement in Processing Speed Following Haploidentical Bone Marrow Transplant With Posttransplant Cytoxan in Children and Adolescents With Sickle Cell Disease
    Prussien KV, Patel DA, Wilkerson K, Armstrong B, Karnik L, de la Fuente J, Kassim AA
    Pediatr Blood Cancer 2020 Jan;67(1):e28001
  • T-Cell Deplete Versus T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Sickle Cell Disease: Where Are We?
    Patel DA, Akinsete AM, Connelly JA, Kassim AA
    Expert Rev Hematol 2019 Sep;12(9):733-752
  • Haploidentical Stem Cell Transplantation With Post-Transplantation Cyclophosphamide for Aggressive Lymphomas: How Far Have We Come and Where Are We Going?
    Patel DA
    World J Oncol 2019 Feb;10(1):1-9
  • Neutrophil-To-Lymphocyte Ratio as a Predictor of Survival in Patients With Triple-Negative Breast Cancer
    Patel DA, Xi J, Luo J, Hassan B, Thomas S, Ma CX, Campian JL
    Breast Cancer Res Treat 2019 Apr;174(2):443-452
  • Diagnostic and Therapeutic Strategies for Patients With Malignant Epidural Spinal Cord Compression
    Patel DA, Campian JL
    Curr Treat Options Oncol 2017 Aug 10;18(9):53
  • 9p24 Abnormalities in Hematologic Malignancies With a Focus on Diffuse Large B-Cell Lymphoma
    Patel DA, Hahn AW, Martin MG
    Med Oncol 2017 May;34(5):95
  • Symptom Reports Are Not Reliable During Ambulatory Reflux Monitoring
    Kavitt RT, Higginbotham T, Slaughter JC, Patel D, Yuksel ES, Lominadze Z, Abou-Ismail A, Pasricha T, Garrett CG, Hagaman D, Vaezi MF
    Am J Gastroenterol 2012 Dec;107(12):1826-32
  • Next-Generation Sequencing and in Silico Analysis Facilitate Prolonged Response to Pazopanib in a Patient With Metastatic Urothelial Carcinoma of the Renal Pelvis
    Hahn AW, Giri S, Patel D, Sluder H, Vanderwalde A, Martin MG
    J Natl Compr Canc Netw 2015 Oct;13(10):1181-5
  • Matrix Metalloproteinase-7 and Premalignant Host Responses in Helicobacter Pylori-Infected Mice
    Ogden SR, Noto JM, Allen SS, Patel DA, Romero-Gallo J, Washington MK, Fingleton B, Israel DA, Lewis ND, Wilson KT, Chaturvedi R, Zhao Z, Shyr Y, Peek RM Jr
    Cancer Res 2010 Jan 1;70(1):30-5

Book Chapters

  • Lymphomas
    Wagner-Johnston N, Patel D
    In: DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology Review, 4th Edition, 2016